bisoprolol has been researched along with Hypotension in 10 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the clinical effects and safety profile of initial monotherapy with either bisoprolol or enalapril in elderly patients with heart failure (HF)." | 9.13 | Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial. ( Dobre, D; Goulder, MA; Krum, H; van Veldhuisen, DJ; Willenheimer, R, 2008) |
| "The cardioselectivity and hypotensive properties of the beta 1-specific beta-blocker bisoprolol were investigated using a single-dose comparison of 10 and 20 mg bisoprolol, 100 mg atenolol, and placebo in 12 hypertensive asthmatic patients." | 9.06 | The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. ( Chatterjee, SS, 1986) |
| "Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 7.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
| "To assess the clinical effects and safety profile of initial monotherapy with either bisoprolol or enalapril in elderly patients with heart failure (HF)." | 5.13 | Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial. ( Dobre, D; Goulder, MA; Krum, H; van Veldhuisen, DJ; Willenheimer, R, 2008) |
| "The cardioselectivity and hypotensive properties of the beta 1-specific beta-blocker bisoprolol were investigated using a single-dose comparison of 10 and 20 mg bisoprolol, 100 mg atenolol, and placebo in 12 hypertensive asthmatic patients." | 5.06 | The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. ( Chatterjee, SS, 1986) |
| "Data were retrospectively collected from 23 patients with HF [age 57±18 years, left ventricular ejection fraction (LVEF) 33±15%] who could not increase the dosage of carvedilol because of dizziness or hypotension, defined as systolic blood pressure<90 mmHg." | 3.79 | Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension. ( Asano, Y; Ichibori, Y; Kanzaki, M; Komuro, I; Minamiguchi, H; Mizote, I; Ohtani, T; Sakata, Y; Taniguchi, T, 2013) |
| "Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
| "Bisoprolol drug was administered at an initial dose of 1." | 1.40 | [Possible applications bisoprolol for heart rate control in young patients with connective tissue dysplasia]. ( Drokina, OV; Nechaeva, GI, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wongcharoen, W | 1 |
| Chotayaporn, T | 1 |
| Chutikhongchalermroj, K | 1 |
| Tantraworasin, A | 1 |
| Saeteng, S | 1 |
| Arworn, S | 1 |
| Rerkasem, K | 1 |
| Phrommintikul, A | 1 |
| Castaño-Amores, C | 1 |
| Antúnez-Rodríguez, A | 1 |
| Pozo-Agundo, A | 1 |
| García-Rodríguez, S | 1 |
| Martínez-González, LJ | 1 |
| Dávila-Fajardo, CL | 1 |
| Chen, YH | 1 |
| Lai, HC | 1 |
| Lee, WL | 1 |
| Liu, TJ | 1 |
| Taniguchi, T | 1 |
| Ohtani, T | 1 |
| Mizote, I | 1 |
| Kanzaki, M | 1 |
| Ichibori, Y | 1 |
| Minamiguchi, H | 1 |
| Asano, Y | 1 |
| Sakata, Y | 1 |
| Komuro, I | 1 |
| Thakrar, R | 1 |
| Shulman, R | 1 |
| Bellingan, G | 1 |
| Singer, M | 1 |
| Nechaeva, GI | 1 |
| Drokina, OV | 1 |
| Dobre, D | 1 |
| van Veldhuisen, DJ | 1 |
| Goulder, MA | 1 |
| Krum, H | 1 |
| Willenheimer, R | 1 |
| Ko, DT | 1 |
| Hebert, PR | 1 |
| Coffey, CS | 1 |
| Curtis, JP | 1 |
| Foody, JM | 1 |
| Sedrakyan, A | 1 |
| Krumholz, HM | 1 |
| Chatterjee, SS | 1 |
4 trials available for bisoprolol and Hypotension
| Article | Year |
|---|---|
Effects of short-term bisoprolol on perioperative myocardial injury in patients undergoing non-cardiac surgery: a randomized control study.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Double-Blind Method; Heart Diseases; Humans; Hyp | 2021 |
Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
Topics: Aged; Antihypertensive Agents; Bisoprolol; Blood Pressure; Bradycardia; Chronic Disease; Cough; Drug | 2008 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
Topics: Adrenergic beta-Antagonists; Aged; Albuterol; Asthma; Bisoprolol; Blood Pressure; Bronchial Provocat | 1986 |
6 other studies available for bisoprolol and Hypotension
| Article | Year |
|---|---|
Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Bisoprolol; Cytochrome P-450 CYP2D6; Genotype; | 2023 |
Iatrogenic Takotsubo Cardiomyopathy Following Overdose Norepinephrine Administration During Percutaneous Coronary Intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Bisoprolol; Coronar | 2020 |
Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Dizziness; Dose-Response Rela | 2013 |
Management of a mixed overdose of calcium channel blockers, β-blockers and statins.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Bradycardia; Calcium Channel Blockers; Cardiac Pacin | 2014 |
[Possible applications bisoprolol for heart rate control in young patients with connective tissue dysplasia].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Blood Pressure; Bradycardia; Connective T | 2014 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |